30-Day Safety | 合法醫療器材資訊網

由 RR Makkar 著作 · 2020 · 被引用 22 次 — Study device and procedure. The Portico valve is composed of three intra-annular, bovine pericardial tissue valve leaflets mounted in a ... Read More

The FlexNav Delivery System study will be conducted as a separate arm of the PORTICO IDE trial and will include up to 200 high or extreme risk subjects; ... Read More

2020年9月22日 — The PORTICO IDE trial showed that TAVR with the self-expanding Portico valve met criteria for noninferiority for safety and efficacy ... Read More

2019年9月27日 — Findings from the PORTICO IDE study have added important new data to the body of TAVR clinical evidence, said Fontana. Read More

2019年9月27日 — SAN FRANCISCO, CA—Portico, a novel self-expanding TAVR device, is noninferior to commercially available valves in extreme- or high-risk patients ... Read More

2019年9月26日 — IDE Study of Portico TAVR System Demonstrates Safety and Efficacy for High-Risk Patients With Severe Aortic Stenosis · Safety, 13.8% vs 9.6%; P ... Read More

The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Portico™ NG Transcatheter Aortic Heart Valve as ... Read More

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial. Prospective, multi-center, randomized, controlled clinical study, designed to evaluate ... Read More

2019年10月2日 — “Transcatheter aortic valve replacement has fundamentally changed how we approach patient care. Findings from the Portico IDE study have added ... Read More